Tag

trial- Pagina 2

1 minuto di lettura

Bioheart (02185.HK) announces clinical result for Iberis-HTN at CIT 2023

(Adnkronos) – SHANGHAI, June 30, 2023 /PRNewswire/ — Bioheart (02185.HK), together with its holding subsidiary Angiocare announces the clinical result for Iberis-HTN at China Interventional Therapeutics 2023. Iberis-HTN is a prospective, multicenter, blinded,

Immediapress

Pharming announces first patient enrolled in pediatric clinical trial of leniolisib

(Adnkronos) – The multinational Phase III study is evaluating leniolisib tablets in children aged 4 to 11 years with APDS, a rare primary immunodeficiency LEIDEN, Netherlands, Feb. 21, 2023 /PRNewswire/ — Pharming Group N.V. (“Pharming” or “the Company”) (EURONEXT Amsterdam:

Adagio Medical Announces Completion of Enrollment in Cryocure-VT Trial, Maps the Pathway to CE-Mark of vCLAS™ VT Ablation Catheter

Immediapress

(Adnkronos) – LAGUNA HILLS, Calif., May 3, 2023 /PRNewswire/ — Adagio Medical, Inc., a leading innovator in catheter ablation technologies for atrial fibrillation (AF)

First Clinical Study of its Kind Shows Positive Impacts from Astaxanthin During Sport Recovery

Immediapress

(Adnkronos) – BRANCHBURG, N.J., March 28, 2023 /PRNewswire/ — A new clinical trial study, published in Frontiers in Nutrition, showed that four weeks of

PeproMene Bio, Inc. Announced Completion of the First Dose Cohort and Opening of the Second Dose Cohort in Its B-cell Non-Hodgkin Lymphoma (B-NHL) Phase 1 Clinical Trial of PMB-CT01 (BAFFR-CAR T Cells)

lunedì, 11 Settembre 2023

Immediapress

(Adnkronos) – IRVINE, Calif., Sept. 11, 2023 /PRNewswire/ — PeproMene Bio, Inc., a clinical-stage biotech company developing novel therapies to treat cancers and immune disorders, today announced that the first dose cohort

Tata Communications launches global, cloud-based 5G Roaming Lab

mercoledì, 23 Agosto 2023

Immediapress

(Adnkronos) – Enables Mobile Network Operators (MNOs) to trial Proof of Concepts (PoCs) before migrating customers to 5G MUMBAI, India, Aug. 23, 2023 /PRNewswire/ — Tata Communications, a global digital ecosystem enabler,

Tata Communications launches global, cloud-based 5G Roaming Lab

mercoledì, 23 Agosto 2023

Immediapress

Signant Acquires DSG to Enhance Its eClinical Solution Suite for Traditional and Decentralized Clinical Trials

lunedì, 17 Luglio 2023

Immediapress

(Adnkronos) – PHILADELPHIA, July 17, 2023 /PRNewswire/ — Signant Health, the leader in evidence generation for modern clinical trials, announced today the acquisition of DSG – a leading provider of electronic data

DISCOVERY LIFE SCIENCES ACCELERATES CLINICAL TRIALS WITH ADDITION OF FULL-SPECTRUM CLINICAL FLOW CYTOMETRY

martedì, 11 Luglio 2023

Immediapress

(Adnkronos) – Integrates state-of-the-art flow cytometry clinical trial services with leading genomics, proteomics, and molecular pathology solutions under one roof HUNTSVILLE, Ala., July 11, 2023 /PRNewswire/ — Discovery Life Sciences (Discovery), the

Tumori, Ai per predire efficacia trattamento, al via studio clinico

giovedì, 22 Giugno 2023

Salute

(Adnkronos) – Predire la risposta al trattamento dei pazienti con tumore del colon-retto metastatico, grazie all’intelligenza artificiale. Con questo obiettivo parte il trial clinico del progetto Revert (taRgeted thErapy for adVanced colorEctal

Suvoda Expands Board of Directors With Addition of Clinical Trial Veteran Irena Webster

martedì, 20 Giugno 2023

Immediapress

(Adnkronos) – PHILADELPHIA, June 20, 2023 /PRNewswire/ — Suvoda LLC, a global clinical trial technology company that specializes in complex studies in therapeutic areas like oncology, central nervous system (CNS), and rare

Novel Transcatheter Valve Repair Device: DRAGONFLY-DMR 12-Month Trial Results Revealed at EuroPCR 2023

lunedì, 19 Giugno 2023

Immediapress

(Adnkronos) – First-Time Clinical Trial Outcomes Show Promising Follow-Up Results HANGZHOU, China, June 19, 2023 /PRNewswire/ — On May 17th, the 12-month results of the DRAGONFLY-DMR pivotal trial were presented at EuroPCR

CORVIA MEDICAL RELEASES TWO-YEAR CLINICAL TRIAL RESULTS CONFIRMING SUSTAINED BENEFIT AND SAFETY OF ITS ATRIAL SHUNT IN HEART FAILURE PATIENTS

lunedì, 22 Maggio 2023

Immediapress

(Adnkronos) – FIRST-EVER PHASE III RANDOMIZED CONTROLLED TRIAL OF ATRIAL SHUNT THERAPY SHOWS CONTINUED PROMISE TEWKSBURY, Mass., May 22, 2023 /PRNewswire/ — Corvia Medical, Inc, a company dedicated to transforming the treatment

Positive Results from Interim Analysis of ‘GEN-001’ Plus avelumab (Bavencio®) Phase II Trial

venerdì, 19 Maggio 2023

Immediapress

(Adnkronos) – SEOUL, South Korea, May 19, 2023 /PRNewswire/ — Genome & Company (CEO: Pae, Jisoo), a global leading microbiome therapeutics developer, announced that this phase II trial (NCT05419362) will continue without modifications

Indietro 1 2 3 Avanti

trial- Pagina 2

Bioheart (02185.HK) announces clinical result for Iberis-HTN at CIT 2023

Pharming announces first patient enrolled in pediatric clinical trial of leniolisib

Adagio Medical Announces Completion of Enrollment in Cryocure-VT Trial, Maps the Pathway to CE-Mark of vCLAS™ VT Ablation Catheter

First Clinical Study of its Kind Shows Positive Impacts from Astaxanthin During Sport Recovery

PeproMene Bio, Inc. Announced Completion of the First Dose Cohort and Opening of the Second Dose Cohort in Its B-cell Non-Hodgkin Lymphoma (B-NHL) Phase 1 Clinical Trial of PMB-CT01 (BAFFR-CAR T Cells)

Tata Communications launches global, cloud-based 5G Roaming Lab

Tata Communications launches global, cloud-based 5G Roaming Lab

Signant Acquires DSG to Enhance Its eClinical Solution Suite for Traditional and Decentralized Clinical Trials

DISCOVERY LIFE SCIENCES ACCELERATES CLINICAL TRIALS WITH ADDITION OF FULL-SPECTRUM CLINICAL FLOW CYTOMETRY

Tumori, Ai per predire efficacia trattamento, al via studio clinico

Suvoda Expands Board of Directors With Addition of Clinical Trial Veteran Irena Webster

Novel Transcatheter Valve Repair Device: DRAGONFLY-DMR 12-Month Trial Results Revealed at EuroPCR 2023

CORVIA MEDICAL RELEASES TWO-YEAR CLINICAL TRIAL RESULTS CONFIRMING SUSTAINED BENEFIT AND SAFETY OF ITS ATRIAL SHUNT IN HEART FAILURE PATIENTS

Positive Results from Interim Analysis of ‘GEN-001’ Plus avelumab (Bavencio®) Phase II Trial

Primo piano

Blocco Tir, governo “sblocca” in Sicilia e Calabria, ma il Golfo di Napoli a rischio isolamento

Dopo gli scontri: cosa prevede il decreto e quali poteri hanno i militari

Il gioco sporco de “la Repubblica” che evoca il Cile di Pinochet in Italia

Schlein: “Serve prevenzione non repressione su sicurezza. Colle ha stoppato poteri ai militari” | Video

Tajani: “A lavoro per autotrasporti. Poteri ai militari? Stop dal Colle, io ero favorevole” | Video

Sponsor

Suggerimenti

trial- Pagina 2

Primo piano

Sponsor